Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Carcinoma
Interventions: DRUG: Ivermectin|DRUG: Balstilmab
Sponsor: Yuan Yuan
Collaborators: Agenus Inc.|Gateway for Cancer Research